A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging

Radiotherapy and Oncology

Volumn 89, Issue 2, 2008, Pages 192-196

  Vilarino Varela, Maria J ^a   Taylor, Alexandra ^a   Rockall, Andrea G ^a   Reznek, Rodney H ^a   Powell, Melanie E B ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Intensity modulated radiotherapy (IMRT); Pelvic lymph node delineation; Ultra small iron oxide particles (USPIO)

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; ENDOMETRIUM CANCER; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME; UTERINE CERVIX CANCER;

CONTRAST MEDIA; ENDOMETRIAL NEOPLASMS; FEMALE; GUIDELINES AS TOPIC; HUMANS; IRON; LYMPH NODES; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; OXIDES; PELVIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; UTERINE CERVICAL NEOPLASMS;

EID: 55149083287     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.023     Document Type: Article

References (27)

1. Mundt A.J., et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52 (2002) 1330-1337
2. Mundt A.J., Mell L.K., and Roeske J.C. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys 56 (2003) 1354-1360
3. Nutting C.M., et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48 (2000) 649-656
4. Portelance L., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 261-266
5. Roeske J.C., et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
6. Hong J.H., et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 249-257
7. Perez C.A., et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 44 (1999) 855-866
8. Bipat S., et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91 (2003) 59-66
9. Scheidler J., et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 278 (1997) 1096-1101
10. Williams A.D., et al. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR Am J Roentgenol 177 (2001) 343-348
11. Adli M., et al. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer?. Int J Radiat Oncol Biol Phys 57 (2003) 230-238
12. Chao K.S., and Lin M. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 54 (2002) 1147-1152
13. Shih H.A., et al. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. Int J Radiat Oncol Biol Phys 63 (2005) 1262-1269
14. Taylor A., et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1604-1612
15. Keller T.M., et al. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results. Eur Radiol 14 (2004) 937-944
16. Koh D.M., et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. Radiology 231 (2004) 91-99
17. Mack M.G., et al. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222 (2002) 239-244
18. Rockall A.G., et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23 (2005) 2813-2821
19. Sigal R., et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol 12 (2002) 1104-1113
20. Vassallo P., et al. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 193 (1994) 501-506
21. Taylor A., Rockall A.G., and Powell M.E. An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. Clin Oncol (R Coll Radiol) 19 (2007) 542-550
22. Heron D.E., et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled. Gynecol Oncol 91 (2003) 39-45
23. Will O., et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7 (2006) 52-60
24. Deserno W.M., et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233 (2004) 449-456
25. Yang W.T., et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 175 (2000) 759-766
26. Benedetti-Panici P., et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 62 (1996) 19-24
27. Sakuragi N., et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85 (1999) 1547-1554